185 results on '"Gouider Emna"'
Search Results
2. Bleeding phenotype in hemophilia carriers : Tunisian center experience
3. Inhibitor in Von Willebrand disease: Two case reports
4. Inhibitor in people living with hemophilia B severe : A four cases report
5. Clot waveform analysis in acute promyelocytic leukemia
6. Identification of genetic defects underlying FVII deficiency in 10 patients belonging to eight unrelated families of the North provinces from Tunisia
7. First report of molecular diagnosis of Tunisian hemophiliacs A: Identification of 8 novel causative mutations
8. Factor VIII haplotypes frequencies in Tunisian hemophiliacs A
9. Clinical phenotype and F7 gene genotype in 40 Tunisian patients with congenital factor VII deficiency
10. Challenges associated with access to plasma‐derived medicinal products in low middle‐income and low‐income countries
11. Clot waveform analysis in acute promyelocytic leukemia
12. P-086 Gestion des concentrés de globules rouges des patients immunisés au sein d’un dépôt de sang
13. P-111 Allo-immunisation anti érythrocytaire en milieu obstétrical : à propos de 1018 femmes
14. P-175 Évaluation des connaissances en transfusion sanguine des internes en médecine
15. P-063 Évaluation des prescriptions des produits sanguins labiles: Expérience monocentrique
16. P-115 Evaluation des non-conformités des demandes de recherche d’anticorps anti érythrocytaires
17. P-108 L’immunisation anti-érythrocytaire au cours de la béta thalassémie
18. Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List
19. Challenges associated with access to plasma‐derived medicinal products in low middle‐income and low‐income countries.
20. A foundation to better care: Target product profile for haemophilia and Von Willebrand disease point‐of‐care diagnostics in low‐resource settings
21. PB2085: EPIDEMIOLOGICAL DESCRIPTION AND PROGNOSIS FEATURES OF MULTIPLE MYELOMA IN A TUNISIAN HAEMATOLOGY CENTER
22. Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List
23. Molecular heterogeneity of factor XI deficiency in Tunisia
24. Low dose prophylaxis and antifibrinolytics: Options to consider with proven benefits for persons with haemophilia
25. Efficacy and safety of von Willebrand factor concentrate almost devoid of factor VIII (Wilfactin®) in paediatric patients under 6 years of age with severe von Willebrand disease.
26. Covid-19 induced blood supply shortage: A Tunisian blood deposit perspective
27. Acquired FVII Deficiency and Acute Myeloid Leukemia: A Case Report and Literature Review
28. Is immune tolerance induction conceivable in haemophilia with inhibitors in a low‐middle income country? Real‐world data from Tunisia
29. L’allo-immunisation anti-érythrocytaire en milieu obstétrical
30. Étiologie des incompatibilités érythrocytaires : à propos de 10 649 cas
31. Transfusion in utero : expérience d’un centre tunisien
32. Contribution and limits of CD157 in the detection of the paroxysmal nocturnal hemoglobinuria clone: a case report
33. Hepatitis E Virus Seroprevalence Among Hemodialysis and Hemophiliac Patients in Tunisia (North Africa)
34. Multiple myeloma with Auer-rod-like inclusions
35. Covid-19 induced blood supply shortage: A Tunisian blood deposit perspective
36. A first case of congenital TTP on the African continent due to a new homozygous mutation in the catalytic domain of ADAMTS13
37. Mutations causing hemophilia B in Algeria: Identification of two novel mutations of the factor 9 gene
38. Activated Partial Thromboplastin Time Clot Waveform Analysis In Hemophilia A
39. Von Willebrand Disease laboratory diagnosis in a low middle income country
40. Multiplex-PCR is a useful and economical method to detect large exon deletions in severe hemophilia A in developing countries: Experience of Tunisia
41. IMMUNOPHENOTYPIC FEATURES OF ACUTE LYMPHOBLASTIC LEUKEMIA IN TUNISIA: 323
42. Clinical phenotype and F7gene genotype in 40 Tunisian patients with congenital factor VII deficiency
43. Is immune tolerance induction conceivable in haemophilia with inhibitors in a low‐middle income country? Real‐world data from Tunisia.
44. Heavy menstrual bleeding in women with inherited bleeding disorders
45. Show me the evidence: Effectiveness of low‐dose prophylaxis
46. Haemodialysis Tunisian patient with acquired factor V inhibitor associated to arteriovenous shunt thrombosis
47. Apport et limites du CD157 pour la recherche d'un clone d'hémoglobinurie paroxystique nocturne Illustration par un cas.
48. Recherche des anticorps irréguliers en milieu obstétrical : 3543 femmes
49. The Glanzmann’s Thrombasthenia in Tunisia: A Cohort Study
50. Hepatitis E virus seroprevalence among hemodialysis and hemophiliac patients in Tunisia (North Africa)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.